Posts Tagged ‘BIIB’

Traders Storm Netflix Weeklies As Shares Continue To Tank

Today’s tickers: NFLX, BIIB, DG & DWA

NFLX - Netflix, Inc. – The bloodbath at Netflix accelerated Thursday afternoon, with shares in the provider of subscription streaming service down 13.0% at $110.59 as of 2:00 pm in New York. Investors began purging their portfolios of NFLX more aggressively in recent weeks, but the stock’s pull back began in July. Shares peaked at an all-time high of $304.79 on July 13, and have since lost nearly 65.0% of their value. Frenzied trading in NFLX weekly options that have one more day of trading left before expiration suggest we may see the stock extend losses through the end of the week. While trading in Sept. ’30 contract calls and puts is mixed across the board, it does appear that bearish positions are more prevalent today. Certainly, the surge in demand for deep out-of-the-money puts on the stock is a sign of the times. More than 2,300 puts changed hands at the Sept. ’30 $100 strike against open interest of 621 contracts. Buyers of at least 930 of the contracts paid an average premium of $0.24 each this afternoon. Sept. ’30 $115 puts are the most active, with volume in excess of 10,100 contracts in play. Buyers of the now deep in-the-money contracts outnumbered sellers, and purchased around 3,800 of the puts for an average premium of $2.05 a-pop. The cost of protective puts on Netflix have climbed steadily throughout the session, helped by the hemorrhaging in its shares, and the more than 15.4% surge in implied volatility to 89.5% today. Options volume on the stock is fast approaching 155,000 contracts as of 2:15 pm EDT.

BIIB - Biogen Idec, Inc. – Fresh prints in deep in-the-money put options on the world’s oldest independent biotechnology company suggests one strategist is positioned for shares in…
continue reading


Tags: , , ,




Another Immune Company Play – Immunomedics

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Cancer is a class of diseases in which a group of cells display uncontrolled growth.  Some cancers invade or intrude upon adjacent tissues, then destroy that tissue/organ, and then spread (metastasize) to other locations in the body via lymph or blood.  These three malignant properties of cancers differentiate them from benign tumors, which do not invade or metastasize.  All of these diseases suggest that there will be a need for personalized therapy, as even within a specific type of cancer, there is wide heterogeneity in clinicopathological features.  For instance, leukemia, lymphoma, myeloma, etc are all lymphoproliferative disorders (where lymphocytes are produced in excess) affect one or more different biological pathways that play a role in lymphomagenesis (the development of B cells and T cells).  Over the past year, on focal point of our  investment virtual portfolio has been smaller companies researching and developing treatments for cancer (CRIS, ARIA, ARRY, SPPI, IMGN).  The next small company with some very interesting prospects in the pipeline is Immunomedics.

Figure 1.  Cancer Prevalence.

In our recent past, monoclonal antibodies (mAbs) were discussed in the context of a mid-tiered pharma, BIIB and smaller biotech, Immunogen (IMGN).  These companies will not be rehashed, but to re-emphasize that mAb and biologics are one of the hottest areas in in biotech.  Small molecules have are not the favorites for now (especially in cancer), and that is most likely due to early stage trials, lack of efficacy, or more likely – patent protection, as biologics/mAbs are harder to show equivolance….and thus have the potential to generate cash for years to come. 

(IMMU) based in New Jersey, is primarily focused on the development of mAb-based products for the targeted treatment of cancer, autoimmune and other diseases.  The company has a number of advanced mAbs that can be used either alone in unlabeled or “naked” form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents (think Inmunogen, but different 'targets').  The company has built a pipeline of therapeutic product candidates that utilize several different mechanisms of action discussed below.  The company also owns a stake in IBC Pharmaceuticals, Inc., which is developing a novel Dock-and-Lock (DNL) methodology. …
continue reading


Tags: , ,




Will We Hold It Wednesday – Back At Our Bottoms

Wow, what a ride! 

As I mentioned in yesterday’s post, we expected the Russell to lead us higher and we picked up both IWM and TNA out of the gate but, of course, we like our leverage so my 9:46 Alert to Members was:

Bottoms WERE:   Dow 10,200, S&P 1,075, Nas 2,200, NYSE 6,800 and Russell 620.  As I said yesterday, "don’t forget there’s a 5% drop to support below these levels). 

For now, we’ll be watching the 2.5% lines at Dow 9,945, S&P 1,048, S&P 1,145, NYSE 6,630 and Russell 605.

My working theory is RUT is weakest because they are getting killed by cut-off of unemployment checks.  That means that an upside play on the RUT could go very well in case they extend benefits today.  I like TNA $37 calls for $3.20 and IWM $63 calls at $1.25.  These are risky of course because if the extension is defeated we could go further down so take quick profits off the table on half to make a buffer and make sure you do have some disaster hedges.

We bounced right off those 2.5% lines and got our $3 copper signal at 10:24 so we knew we were good to go as we took those calls plus GOOG, BAC, GS, QQQQ, IBM, TXN, AAPL, WFR and BIIB.  Other than BIIB, which is a long-term spread, all of our shopping was done by noon and the rest of the day we just said "Wheeeeeeeeeeeeeee!" as the market went up and up and up – and they haven’t even extended the unemployment benefits yet! 

I have been saying we need to keep an eye on copper $3 during this whole market breakdown as $3 copper is NOT the right price for a Global Depression, which is what the market has been pricing in and at 10:24 as copper hit our bull target, I said to Members: "Copper $3!  That’s like the little snapping sound when the bear takes the bait in the bear trap."  Now we are back testing our "bottoms" which, as I said yesterday, are really the middles of our 5% Rule range but our view of earnings season so far is that we shouldn’t be in the lower end of the range and the recent action, as I summed it up in yesterday’s post, was silly

Now things…
continue reading


Tags: , , , , , , , , , , , , , ,




Anadys Pharm-Bull Eyes Upside, Buys Call Spread

Today’s tickers: ANDS, FXI, GME, BIIB, TRA, WYN & AES

ANDS – Anadys Pharmaceuticals, Inc. – Biotechnology firm, Anadys Pharmaceuticals, enticed a long-term bullish investor to shell out option premium in order to establish a debit call spread in the September contract. ANDS-shares are trading 0.45% higher on the day to $2.19 as of 2:25 pm (ET). The optimistic options player purchased 3,000 calls at the September $2.5 strike for a premium of $0.55 apiece, marked against the sale of 3,000 calls at the higher September $5.0 strike for $0.15 each. The net cost of the call spread amounts to $0.30 per contract. The transaction positions the trader to accrue maximum potential profits of $2.20 per contract should shares of the underlying stock surge 128.3% over the current price to $5.00 by expiration day in September. Shares must rally at least 27.85% in order for the investor to break even on the trade at a share price of $2.80 each.

FXI – iShares FTSE/Xinhua China 25 Index Fund – The China exchange-traded fund, which corresponds to the price and yield performance of an underlying index invested in 25 of the largest and most liquid Chinese companies, realized a 0.95% decline in the price of its underlying shares to $41.13 this afternoon. Investors touting long-term pessimistic outlooks on the fund purchased put options in the January 2011 contract. It appears some 25,500 put options were picked up at the January 2011 $35 strike for an average premium of $2.50 apiece. Put-purchasers could be seeking downside protection on long underlying share positions. On the other hand, the contracts may have been purchased outright by extremely bearish individuals anticipating a 21% decline in shares of the FXI to $32.50 ahead of expiration. Investors in this case reel in profits should the price of the underlying fund trade below $32.50 in the next nine months to expiration day in January.

GME – GameStop Corp. – Shares of the largest retailer of video games jumped more than 5.10% during the trading session to $19.22 due to speculation the firm may be acquired. Despite the current rally in GameStop’s shares to $19.22 today, the stock still stands 41.45% below its 52-week high of $32.82 attained back on April 13, 2009. Investors taken-in by the takeover rumors purchased approximately 10,300 calls at the March $20 strike for an average premium of $0.47 per contract. The call options…
continue reading


Tags: , , , , , ,




Cisco Call Options Fly off the Shelves

Today’s tickers: CSCO, DRYS, CIGX, AES, V, MCD, BIIB, SNE, GME & VALE

CSCO – Cisco Systems, Inc. – Bullish call-buying dominated options trading patterns on Cisco today on news the firm is slated to “make a significant announcement that will forever change the internet and its impact on consumers, businesses and governments.” Cisco’s shares jumped 4.15% to a new 52-week high of $26.25 during the session on a target share price upgrade to $28.00 from $26.00 at JPMorgan Chase & Co. Bullish traders purchased approximately 15,800 in-the-money calls at the March $26 strike for a premium of $0.33 apiece and coveted 9,300 calls at the higher March $27 strike for an average premium of $0.10 each. Uber-bullish individuals bought 4,000 calls at the March $28 strike for just two pennies premium per contract. Investors long the closest-to-the-money March $26 strike calls are positioned to accrue profits if Cisco’s shares trade above $26.33 ahead of expiration day. The surge in demand for options on the stock as well as uncertainty surrounding tomorrow’s announcement lifted the reading of overall options implied volatility on Cisco by 17.5% to 22.85% in afternoon trading.

DRYS – DryShips, Inc. – Dry-bulk shipping company, DryShips, Inc., experienced a short-lived dip in the price of its shares in morning trading, but regained its footing this afternoon, rallying 7.77% to $6.10 with about forty minutes remaining in the session. Call-buying action flooded DRYS today with approximately 22,300 now in-the-money calls picked up at the near-term March $6 strike for an average premium of $0.22 apiece. Nearly 12,000 calls were coveted at the higher March $7 strike for $0.05 premium per contract. Optimism spread to the same strike prices in the April contract, as well. Investors secured roughly 11,600 long in-the-money calls at the April $6 strike for an average premium of $0.39 each. Traders bought another 4,000 call options at the higher April $7 strike for $0.16 per contract. Options traders exchanged more than 130,000 contracts on DryShips during the session, which represents about 27% of total existing open interest on the stock of 480,443 contracts. Options implied volatility jumped approximately 34.8% this afternoon to 60.26%.

CIGX – Star Scientific, Inc. – Shares of the maker of dissolvable smokeless tobacco products surged 6.70% to $1.12 today, inspiring one investor to establish a bullish risk reversal on the stock in the August contract. The trader appears to have sold…
continue reading


Tags: , , , , , , , , ,




Bullish Player Forecasts Sunnier Skies Over B of A by August Expiration

Today’s tickers: BAC, PBR, UAUA, BIIB, USO, MAC, NLY, NYX, CVS & KGC

BAC – Bank of America Corp. – Options trading in the August contract on Bank of America suggests a significant recovery in the value of the underlying shares within the next seven months to expiration. Shares spent the majority of the trading session in the red, but rallied in late-afternoon trading, improving 0.20% to $14.51. It looks like one trader sold 6,000 put options at the August $12 strike for a premium of $0.86 each in order to partially finance the purchase of 6,000 calls at the higher August $16 strike at a premium of $1.12 apiece. The net cost of the bullish risk reversal amounts to $0.26 per contract, positioning the investor to accumulate profits above a breakeven share price of $16.26. Shares of the underlying stock must rally at least 12% over the current price for the trader to break even on the transaction by August expiration. We note that B of A’s shares traded above $16.50 as recently as January 20, 2010.

PBR – Petroleo Brasileiro SA ADR – Shares of Brazil’s state-controlled oil company, Petroleo Brasileiro SA, rallied 3.70% to $39.60 today perhaps after the company stated natural gas output will increase to 93 million cubic meters in 2011, up from 85 million cubic meters in the current year. PetroBras-bulls stampeded the February contract this afternoon to sell roughly 15,000 puts at the February $39 strike for an average premium of $0.83 apiece. Investors selling short the puts retain the full premium received today as long as shares of the underlying stock trade above $39.00 through expiration day. Put-sellers are apparently happy to have shares put to them for an effective price of $38.17 each should the put contracts land in-the-money at expiration.

UAUA – UAL Corp. – Shares of the owner and operator of United Airlines surged 17% to a new 52-week high of $15.27 today amid better-than-expected unit revenue for the month of January. Optimistic option traders dabbled in both calls and puts to take bullish positions on UAL Corp. Investors sold 2,300 puts at the February $13 strike, taking in an average premium of $0.16 per contract. Put sellers retain the full premium as long as UAUA’s share price remains above $13.00 through expiration. One the call side, traders picked up roughly 2,000 contracts at the now in-the-money February $15…
continue reading


Tags: , , , , , , , , ,




Option Traders Latch Onto Rambus Chatter

Today’s tickers: RMBS, BIIB, IYF, OSK, GNW, XOP & S

RMBS - The latest from the rumor mill suggests that the memory chip maker may be the target of a buyout by Samsung Electronics for approximately $25.00 to $27.50 per share. Some analysts reported that such rumors are likely unfounded, and we should note also this is currently idle market chatter. Nevertheless, frenzied options activity was observed on the stock amid a more than 8% rally to $17.22. Option traders concentrated their efforts on out-of-the-money calls in the near-term September contract. Nearly 6,000 calls were picked up at the September 18 strike for about 68 cents each. The higher September 19 strike had 5,000 calls purchased for an average of 47 cents apiece. Finally, the most bullish investors looked as high as the September 20 strike to gather up more than 8,000 calls for 37 cents per contract. Rumors remain unconfirmed, but traders holding the call options are positioned to bank some serious profits if the buyout speculation proves accurate by expiration this month. – Rambus Inc. –

BIIB - The largest maker of medicines for multiple sclerosis announced that it has extended an unsolicited takeover bid, worth $356 million in cash, for its drug partner Facet Biotech Corporation. Shares of BIIB rose more than 2% during the session to the current price of $51.03. Perhaps the takeover bid inspired the bullish reversal strategy we observed in the April contract today. One investor appears to have shed 10,000 puts at the April 35 strike price for a premium of 90 cents apiece in order to partially offset the cost of purchasing 5,000 calls at the higher April 55 strike for 3.80 each. The net cost of the transaction amounts to 2.00 per contract. The investor responsible for the trade will begin to accrue profits if shares of BIIB rally approximately 12% from the current price to breach the breakeven point at $57.00 by expiration day. – Biogen IDEC, Inc. –

IYF - Shares of the IYF have moved slightly higher during the session, gaining less than 0.5% to arrive at the current price of $50.09. The ETF jumped onto our ‘most active by options volume’ market scanner this afternoon after a large bullish reversal play was initiated in the November contract. We note that the transaction was tied to stock. The investor responsible for the trade shed 20,000 puts at the November 40…
continue reading


Tags: , , , , , ,




Lifting the Axle

Today’s tickers: AXL, PALM, POT, XLF, EMR, AA, & BIIB

AXL – Shares of the Tier 1 supplier of parts and components to the automotive industry have rallied more than 8.5% to a whopping $2.78 today. The improvement in the stock, since touching down to just 26 cents on March 9, 2009, prompted one uber-bullish investor to enact a call spread in the October contract. The trader seems to have determined that the $300 million cut in AXL’s second- and third-quarter revenue streams, felt in the wake of its bankruptcy-brethren GM and Chrysler, will have been replenished by the fall. The summer shutdowns by the automakers are certainly painful for the time being as the two behemoths account for 90% of AXL’s annual revenue. Hoping for a ridiculous turnaround in circumstances, the investor initiated the purchase of 10,000 calls at the October 5.0 strike price for a premium of 40 cents apiece which were spread against the sale of 10,000 calls at the higher October 7.5 strike for about 15 cents each. The net cost of the transaction amounts to 25 cents and yields maximum potential profits of 2.25. Shares will need to grow with the tenacity of the Hulk in order to rally more than 169% over the next five months. – American Axle & Manufacturing Holdings, Inc.

PALM – Put options on the mobile devices company were favored by option investors on the scene today amid a share price decline of 3% to $13.22. One trader targeted the July contract in order to initiate a bearish ratio put spread. The transaction involved the purchase of 2,800 puts at the in-the-money July 14 strike puts for a premium of 2.82 per contract spread against the sale of 5,600 puts at the lower July 10 strike for about 70 cents apiece. The net cost of the pessimistic play on PALM amounts to 1.42 and yields maximum potential profits of 2.58 to the trader if shares decline down to $10.00 by expiration. Profits begin to amass if shares fall another 5% to the breakeven point at $12.58 by expiration next month. Option implied volatility has ramped up significantly over the past couple of days from 93% at the start of Thursday to the current reading of 112% ahead of the release of The Pre tomorrow. – Palm, Inc.

POT– We observed an interesting use of out-of-the-money puts by one investor on
continue reading


Tags: , , , , , ,




Emerging market options see maelstrom of action

Today’s tickers: EEM, QCOM, EWZ, FRX, CSX, RIMM & BIIB

EEM iShares MSCI Emerging Market ETF – For the most part, option traders were observed shedding calls and buying puts as though they were going out of style, despite the more than 5.5% rally in shares to $27.09. The trading pattern on the emerging markets ETF was bearish except for one investor who went against the grain today. At the April 25 strike price about 30,500 puts were purchased for an average premium of 48 cents each, while the June contract enticed investors looking for protection at even lower strikes. At the June 21 strike price 10,000 puts were picked up for 66 cents apiece whereas 5,000 puts were coveted at the June 24 strike for 1.37 apiece. Call options were sold in high volume, with 5,000 shed at the in-the-money June 24 strike for 4.45, some traders were seen banking gains on the current share price rally. Similarly, 10,000 calls were sold at the now in-the-money June 27 strike for 2.55 per contract. Some investors do not see the rally continuing through $31.00 by expiration in June as 32,500 calls were shed at the June 31 strike price for 90 cents apiece. Finally, the contrarian trade occurred in the midst of the put buying and call selling late in the trading day. One investor sold 25,000 puts at the June 24 strike for 1.32 each in order to fund the purchase of 25,000 calls at the June 29 strike price for a premium of 1.64. The net cost of getting long of the bullish call options amounts to 32 cents. This optimistic trader will begin to reel in profits if shares can breach the breakeven point at $29.32 by expiration.

QCOM Qualcomm, Inc. – The wireless communications company has experienced a 3% increase in shares to $40.93. QCOM appeared on our ‘most active by options volume’ market scanner as more than 75,000 contracts traded hands throughout the day. Put options traded twice for each call in action yielding a put-to-call ratio of 2.0. The May contract in particular caught our eye as one investor appears to have initiated a ratio put spread. At the May 40 strike price 7,000 puts were purchased for an average premium of 2.37 while the May 35 strike had about 14,000 puts sell for 86 cents apiece. By selling twice as many put options…
continue reading


Tags: , , , , , ,




 
 
 

Phil's Favorites

Passive Products and Active Users

 

Passive Products and Active Users

Courtesy of 

The 20 largest ETFs have $1.556 trillion in assets. While the indexes they track are passive, their users are anything but. Over the previous twelve months, the total trading volume in these products was a whopping $11.529 trillion.

A recent paper from ...



more from Ilene

Insider Scoop

10 Stocks To Watch For October 17, 2019

Courtesy of Benzinga

Some of the stocks that may grab investor focus today are:

  • Wall Street expects Morgan Stanley (NYSE: MS) to report quarterly earnings at $1.13 per share on revenue of $9.70 billion before the opening bell. Morgan Stanley shares rose 0.9% to $43.19 in after-hours trading.
  • Analysts expect Intuitive Surgical, Inc. (NASDAQ: ISRG) ...


http://www.insidercow.com/ more from Insider

Zero Hedge

In The Fed, We Trust?!

Courtesy of ZeroHedge View original post here.

Authored by Michael Lebowitz and Jack Scott via RealInvestmentAdvice.com,

Part one of this article can be found HERE.

President Trump recently nominated Judy Shelton to fill an open seat on the Federal Reserve Board. She was recently quoted by the Washington Post as follows:

“(I) would lower rates as fast, as efficiently, and as expeditiously...



more from Tyler

The Technical Traders

Market Trend Change Triggered Today

Courtesy of Technical Traders

CLICK HERE TO GET REAL TIME TRADE ALERTS!

...

more from Tech. Traders

Kimble Charting Solutions

High Times Going To Return For Pot Stocks?

Courtesy of Chris Kimble

High times for pot stocks do not come to mind when looking at this 6-pack!

On average, these stocks have declined nearly 50% since recent highs.

Are pot stocks about to experience “High Times” again?

The large declines since recent highs has each of these stocks testing support at each (1).

If the pot stocks are to move higher, these key support lines need to hold.

Out of these six stocks, ABBV is reflecting relative strength to the others, as it has been moving higher off support the past 60-days.

...

more from Kimble C.S.

Chart School

Review of Andrew CardWell RSI with Wyckoff price waves

Courtesy of Read the Ticker

RSI measures relative strength of price action of a set period versus prior set periods. It helps review the price swings or waves, the power of each price thrust into new ground, or lack of it. Price thrust like many things relies on energy, and energy is not a constant, it has a birth, a life and a death and relative strength helps us see that cycle. 

More from RTT Tv






Chart in video

Click for popup. Clear your browser cache if image is not showing.



...

more from Chart School

Digital Currencies

Zuck Delays Libra Launch Date Due To Issues "Sensitive To Society"

Courtesy of ZeroHedge View original post here.

Authored by William Suberg via CoinTelegraph.com,

Facebook is taking a much more careful approach to Libra than its previous projects, CEO Mark Zuckerberg has confirmed. 

“Obviously we want to move forward at some point soon [and] not have this take many years to roll out,” he said. “But ...



more from Bitcoin

Lee's Free Thinking

Look Out Bears! Fed New QE Now Up to $165 Billion

Courtesy of Lee Adler

I have been warning for months that the Fed would need new QE to counter the impact of massive waves of Treasury supply. I thought that that would come later, rather than sooner. Sorry folks, wrong about that. The NY Fed announced another round of new TOMO (Temporary Open Market Operations) today.

In addition to the $75 billion in overnight repos that the Fed issued and has been rolling over since Tuesday, next week the Fed will issue another $90 billion. They’ll come in the form of three $30 billion, 14 day repos to be offered next week.

That brings the new Fed QE to a total of $165 billion. Even in the worst days of the financial crisis, I can’t remember the Fed ballooning its balance sheet by $165 bi...



more from Lee

Biotech

The Big Pharma Takeover of Medical Cannabis

Reminder: We are available to chat with Members, comments are found below each post.

 

The Big Pharma Takeover of Medical Cannabis

Courtesy of  , Visual Capitalist

The Big Pharma Takeover of Medical Cannabis

As evidence of cannabis’ many benefits mounts, so does the interest from the global pharmaceutical industry, known as Big Pharma. The entrance of such behemoths will radically transform the cannabis industry—once heavily stigmatized, it is now a potentially game-changing source of growth for countless co...



more from Biotech

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.

Members' Corner

Despacito - How to Make Money the Old-Fashioned Way - SLOWLY!

Are you ready to retire?  

For most people, the purpose of investing is to build up enough wealth to allow you to retire.  In general, that's usually enough money to reliably generate a year's worth of your average income, each year into your retirement so that that, plus you Social Security, should be enough to pay your bills without having to draw down on your principle.

Unfortunately, as the last decade has shown us, we can't count on bonds to pay us more than 3% and the average return from the stock market over the past 20 years has been erratic - to say the least - with 4 negative years (2000, 2001, 2002 and 2008) and 14 positives, though mostly in the 10% range on the positives.  A string of losses like we had from 2000-02 could easily wipe out a decades worth of gains.

Still, the stock market has been better over the last 10 (7%) an...



more from Our Members

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>